Aprepitant

Overview

4.5 out of 5 (35 Reviews)

Credits

1.00

Post Assessment Questions

7

Start Date

1 Sep 2023

Last Review Date

11 Jan 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Aprepitant was initially developed to prevent chemotherapy-induced nausea and vomiting (CINV). However, its applications have since broadened to include postoperative nausea and vomiting (PONV). Aprepitant belongs to the neurokinin-1 antagonist class of medications and has received approval from the Food and Drug Administration (FDA) for both indications. This activity outlines and reviews the indications, actions, and contraindications of aprepitant as a valuable drug in preventing CINV and PONV. This activity also highlights the mechanism of action, adverse event profile, monitoring, and relevant interactions pertinent for healthcare team members involved in the care of patients undergoing highly emetogenic chemotherapy or general anesthesia.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify appropriate patient candidates for aprepitant therapy based on the risk factors for chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting.

  • Assess and monitor patients for potential adverse events associated with aprepitant therapy and promptly manage any complications.

  • Select appropriate dosing regimens of aprepitant based on the specific chemotherapy or anesthesia regimen.

  • Collaborate with healthcare professionals to ensure proper dosing, monitor drug interactions, and address concerns related to aprepitant for optimal patient outcomes.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 1.00 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Bhupendra M. on 5/6/2021

Michael B. on 8/29/2021

Mike G. on 9/3/2021

Androcles L. on 12/31/2021

Teresa c. on 1/2/2022

Mary Y. on 1/23/2022

James M. on 2/4/2022

Jennifer K. on 2/27/2022

Yvonne H. on 4/2/2022

Lindsay W. on 4/19/2022

Catherine. C. on 5/6/2022

Matthew S. on 5/31/2022

Terry H. on 9/19/2022

Tamatha J. on 10/5/2022

Mark O. on 10/23/2022

OCEAN C. on 11/18/2022

Anna B. on 12/4/2022

Lauren K. on 12/5/2022

Scott C. on 1/14/2023

Danielle F. on 1/16/2023

judy s. on 1/19/2023

Kacie B. on 6/19/2023

none

RAQUEL . on 7/25/2023

Johana R. on 8/21/2023

Kelly K. on 8/26/2023

Donna P. on 10/4/2023

Essam M. on 10/23/2023

Ann C. on 11/2/2023

Walter G. on 12/2/2023

Bhavani K. on 12/8/2023

Dr Sruthi G. on 12/12/2023

ROBERT Z. on 12/20/2023

Richard S. on 12/20/2023

Mark A. on 12/23/2023

Hedy M. on 12/31/2023

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6674 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7926.5 hours of CE.

Single Activity

Take this single activity

$25 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$199 per 1 year per user